Pages that link to "Q46042915"
Jump to navigation
Jump to search
The following pages link to Comparing safety and efficacy of first-line irinotecan/fluoropyrimidine combinations in elderly versus nonelderly patients with metastatic colorectal cancer: findings from the bolus, infusional, or capecitabine with camptostar-celecoxib study (Q46042915):
Displaying 25 items.
- Incidence and relative risk of grade 3 and 4 diarrhoea in patients treated with capecitabine or 5-fluorouracil: a meta-analysis of published trials (Q27028095) (← links)
- Safety of bevacizumab in treating metastatic colorectal cancer: a systematic review and meta-analysis of all randomized clinical trials (Q31127134) (← links)
- The effect of geriatric intervention in frail elderly patients receiving chemotherapy for colorectal cancer: a randomized trial (GERICO). (Q33851067) (← links)
- 5-Fluorouracil or capecitabine in the treatment of advanced colorectal cancer: a pooled-analysis of randomized trials (Q34180260) (← links)
- Bevacizumab treatment in the elderly patient with metastatic colorectal cancer (Q34899949) (← links)
- Treatment considerations in elderly colorectal cancer patients. (Q35234803) (← links)
- Chemotherapy for colorectal cancer in the elderly (Q35567604) (← links)
- First-Line Cetuximab Plus Capecitabine in Elderly Patients with Advanced Colorectal Cancer: Clinical Outcome and Subgroup Analysis According toKRASStatus from a Spanish TTD Group Study (Q35863869) (← links)
- Efficacy and safety of bevacizumab plus chemotherapy compared to chemotherapy alone in previously untreated advanced or metastatic colorectal cancer: a systematic review and meta-analysis (Q36112303) (← links)
- Bevacizumab plus chemotherapy in elderly patients with previously untreated metastatic colorectal cancer: single center experience (Q36857679) (← links)
- Palliative chemotherapy in advanced colorectal cancer patients 80 years of age and older (Q36989058) (← links)
- Role of cetuximab in first-line treatment of metastatic colorectal cancer (Q37708010) (← links)
- Role of the antiangiogenic agent bevacizumab in the treatment of elderly patients with metastatic colorectal cancer (Q37820653) (← links)
- Chemoprevention, chemotherapy, and chemoresistance in colorectal cancer. (Q38002127) (← links)
- Metastatic colorectal cancer in the elderly: An overview of the systemic treatment modalities (Review). (Q38032558) (← links)
- Non-steroidal anti-inflammatory treatment in cancer cachexia: a systematic literature review (Q38047351) (← links)
- Doublet chemotherapy vs. single-agent therapy with 5FU in elderly patients with metastatic colorectal cancer. a meta-analysis (Q38534405) (← links)
- Synchronous colorectal liver metastases: focus on the elderly : An Effectiveness Study from Routine Care. (Q38627295) (← links)
- Efficacy and Safety of FOLFIRI Regimen in Elderly Versus Nonelderly Patients with Metastatic Colorectal or Gastric Cancer (Q38956434) (← links)
- Thromboembolic Events Associated with Bevacizumab plus Chemotherapy for Patients with Colorectal Cancer: A Meta-Analysis of Randomized Controlled Trials (Q40975248) (← links)
- Novel quality indicators for metastatic colorectal cancer management identify significant variations in these measures across treatment centers in Australia. (Q41076505) (← links)
- Feasibility and efficacy of capecitabine and FOLFIRI in patients aged 65 years and older with advanced colorectal cancer: a retrospective analysis (Q43289305) (← links)
- Retrospective study as first-line chemotherapy combined anti-VEGF antibody with fluoropyrimidine for frail patients with unresectable or metastatic colorectal cancer (Q44102658) (← links)
- Comparative Safety of Targeted Therapies for Metastatic Colorectal Cancer between Elderly and Younger Patients: a Study Using the International Pharmacovigilance Database (Q47746831) (← links)
- Current Treatment Strategies for Elderly Patients with Metastatic Colon Cancer (Q92242538) (← links)